-
Something wrong with this record ?
Fluid Therapy: Double-Edged Sword during Critical Care
J. Benes, M. Kirov, V. Kuzkov, M. Lainscak, Z. Molnar, G. Voga, X. Monnet,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
NV15-31881A
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013
ProQuest Central
from 2013
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2012-12-04
Open Access Digital Library
from 2013-01-01
CINAHL Plus with Full Text (EBSCOhost)
from 2013-01-01
Medline Complete (EBSCOhost)
from 2013-01-01
Health & Medicine (ProQuest)
from 2013
Wiley-Blackwell Open Access Titles
from 2001
ROAD: Directory of Open Access Scholarly Resources
from 2013
PubMed
26798642
DOI
10.1155/2015/729075
Knihovny.cz E-resources
- MeSH
- Hemodynamics * MeSH
- Cardiovascular Diseases * physiopathology therapy MeSH
- Humans MeSH
- Monitoring, Physiologic * MeSH
- Critical Care methods MeSH
- Shock * physiopathology therapy MeSH
- Fluid Therapy * adverse effects methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Fluid therapy is still the mainstay of acute care in patients with shock or cardiovascular compromise. However, our understanding of the critically ill pathophysiology has evolved significantly in recent years. The revelation of the glycocalyx layer and subsequent research has redefined the basics of fluids behavior in the circulation. Using less invasive hemodynamic monitoring tools enables us to assess the cardiovascular function in a dynamic perspective. This allows pinpointing even distinct changes induced by treatment, by postural changes, or by interorgan interactions in real time and enables individualized patient management. Regarding fluids as drugs of any other kind led to the need for precise indication, way of administration, and also assessment of side effects. We possess now the evidence that patient centered outcomes may be altered when incorrect time, dose, or type of fluids are administered. In this review, three major features of fluid therapy are discussed: the prediction of fluid responsiveness, potential harms induced by overzealous fluid administration, and finally the problem of protocol-led treatments and their timing.
Faculty of Medicine University of Ljubljana Vrazov trg 2 SI 1000 Ljubljana Slovenia
Medical ICU General Hospital Celje Oblakova 5 SI 3000 Celje Slovenia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000597
- 003
- CZ-PrNML
- 005
- 20201105151659.0
- 007
- ta
- 008
- 170103s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2015/729075 $2 doi
- 024 7_
- $a 10.1155/2015/729075 $2 doi
- 035 __
- $a (PubMed)26798642
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Benes, Jan $u Department of Anesthesia and Intensive Care Medicine, University Teaching Hospital and Faculty of Medicine in Plzen, Charles University Prague, Alej Svobody 80, 32300 Plzen, Czech Republic.
- 245 10
- $a Fluid Therapy: Double-Edged Sword during Critical Care / $c J. Benes, M. Kirov, V. Kuzkov, M. Lainscak, Z. Molnar, G. Voga, X. Monnet,
- 520 9_
- $a Fluid therapy is still the mainstay of acute care in patients with shock or cardiovascular compromise. However, our understanding of the critically ill pathophysiology has evolved significantly in recent years. The revelation of the glycocalyx layer and subsequent research has redefined the basics of fluids behavior in the circulation. Using less invasive hemodynamic monitoring tools enables us to assess the cardiovascular function in a dynamic perspective. This allows pinpointing even distinct changes induced by treatment, by postural changes, or by interorgan interactions in real time and enables individualized patient management. Regarding fluids as drugs of any other kind led to the need for precise indication, way of administration, and also assessment of side effects. We possess now the evidence that patient centered outcomes may be altered when incorrect time, dose, or type of fluids are administered. In this review, three major features of fluid therapy are discussed: the prediction of fluid responsiveness, potential harms induced by overzealous fluid administration, and finally the problem of protocol-led treatments and their timing.
- 650 12
- $a kardiovaskulární nemoci $x patofyziologie $x terapie $7 D002318
- 650 _2
- $a péče o pacienty v kritickém stavu $x metody $7 D003422
- 650 12
- $a tekutinová terapie $x škodlivé účinky $x metody $7 D005440
- 650 12
- $a hemodynamika $7 D006439
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a monitorování fyziologických funkcí $7 D008991
- 650 12
- $a šok $x patofyziologie $x terapie $7 D012769
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kirov, Mikhail $u Department of Anesthesiology and Intensive Care Medicine, Northern State Medical University, Arkhangelsk 163000, Russia.
- 700 1_
- $a Kuzkov, Vsevolod $u Department of Anesthesiology and Intensive Care Medicine, Northern State Medical University, Arkhangelsk 163000, Russia.
- 700 1_
- $a Lainscak, Mitja $u Department of Cardiology and Department of Research and Education, General Hospital Celje, Oblakova 5, SI-3000 Celje, Slovenia; Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1000 Ljubljana, Slovenia.
- 700 1_
- $a Molnar, Zsolt $u Department of Anaesthesiology and Intensive Therapy, Faculty of Medicine, University of Szeged, 6 Semmelweis Street, Szeged 6725, Hungary.
- 700 1_
- $a Voga, Gorazd $u Medical ICU, General Hospital Celje, Oblakova 5, SI-3000 Celje, Slovenia.
- 700 1_
- $a Monnet, Xavier $u Medical ICU, Paris-Sud University Hospitals, Inserm UMR-S 999, Paris-Sud University, 94 270 Le Kremlin-Bicêtre, France.
- 773 0_
- $w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2015, č. - (2015), s. 729075
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26798642 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20201105151656 $b ABA008
- 999 __
- $a ok $b bmc $g 1179737 $s 961164
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 2015 $c - $d 729075 $e 20151222 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
- GRA __
- $a NV15-31881A $p MZ0
- LZP __
- $a Pubmed-20170103